Survey on the Pharmacy Follow-up of Alli Purchasers
October 25, 2012 updated by: GlaxoSmithKline
Survey on the Pharmacy Follow up of Alli Purchasers
To assess the feasibility and acceptability of genuine pharmacy follow up of people wishing to lose weight.
Study Overview
Study Type
Observational
Enrollment (Actual)
80
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Consumers purchasing orlistat in a pharmacy setting
Description
Inclusion Criteria:
- Individuals who have been recognized as being eligible for treatment, who have agreed to pharmacy follow up, and have given their informed consent to take part in the survey.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
60 mg Orlistat
Purchased by consumer
|
60 mg
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Physical activity
Time Frame: baseline to 1 year
|
baseline to 1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in dietary behavior
Time Frame: baseline to 1 year
|
baseline to 1 year
|
|
Evaluation of care pathway (e.g., consultation with doctors, use of nutritional information)
Time Frame: baseline to 1 year
|
baseline to 1 year
|
|
Satisfaction with management (i.e., results on weight and treatment comfort)
Time Frame: baseline to 1 year
|
baseline to 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
December 1, 2010
Study Completion (Actual)
December 1, 2010
Study Registration Dates
First Submitted
March 29, 2010
First Submitted That Met QC Criteria
June 30, 2011
First Posted (Estimate)
July 4, 2011
Study Record Updates
Last Update Posted (Estimate)
October 29, 2012
Last Update Submitted That Met QC Criteria
October 25, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- W5350856
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.